AXIM - AXIM Biotechnologies, Inc.
| Previous Close | 5.42 |
| Open | 5.41 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 5.21 - 5.42 |
| 52 Week Range | 3.24 - 13.45 |
| Volume | 12,551 |
| Avg. Volume | 38,925 |
| Market Cap | 300.528M |
| Beta | -10.66 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 |
| Earnings Date | May 1, 2018 - May 7, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire•2 days ago
AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal Activities
NEW YORK, April 18, 2018-- AXIM ® Biotechnologies, Inc.,, a world leader in cannabinoid research and development, today announced that the European Patent Office has published a patent application owned ...
- Motley Fool•9 days ago
3 Marijuana Stocks You Couldn't Pay Me to Buy
These pot stocks are bad news for investors.
- GlobeNewswire•17 days ago
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
NEW YORK, April 03, 2018-- AXIM ® Biotechnologies, Inc., a world leader in cannabinoid research and development, today announced that it has entered into a Memo of Understanding with a leading Korean specialty ...
- Motley Fool•18 days ago
This Pot Stock Is Trading Below Its Book Value
Despite being an apparent book value bargain, this marijuana stock comes with big risks.
- GlobeNewswire•last month
AXIM Biotech to Attend BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference in New York
NEW YORK, March 21, 2018-- AXIM ® Biotechnologies, Inc., a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM ...
- Zacks Small Cap Research•last month
AXIM Biotechnologies (AXIM) Advancing Multi-faceted Medical CBD and THC Pipeline
OTC:AXIM Summary • AXIM Biotechnologies (OTC:AXIM) holds the intellectual property rights to the controlled-release, trans-mucosal (chewing gum) drug delivery platform for medical cannabinoids. o The company ...
- GlobeNewswire•last month
AXIM Biotechnologies Reports Year End 2017 Results
NEW YORK, March 19, 2018-- AXIM ® Biotechnologies, Inc., a world leader in cannabinoid research and development, today announced financial results for the quarter and year ended December 31, 2017, and ...
- PR Newswire•2 months ago
Medical Marijuana, Inc. Major Investment AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules
SAN DIEGO , Feb. 28, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced that its major investment company AXIM® ...
- GlobeNewswire•2 months ago
AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules
NEW YORK, Feb. 27, 2018-- AXIM ® Biotechnologies, the world leader in cannabinoid research and development, today announced the first-ever successful execution of proprietary current good manufacturing ...
- GlobeNewswire•2 months ago
CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction
NEW YORK, Feb. 21, 2018--. AXIM ® Biotechnologies, Inc., a world leader in cannabinoid research and development, today announced that CBS News covered the Company’ s recent patent filing on a controlled-release ...
- GlobeNewswire•2 months ago
AXIM Biotech Enters Into Distribution Agreement for Proprietary Cannabinoid-Based Nutraceutical Chewing Gum Product CanChew+ Throughout Thailand
NEW YORK, Feb. 06, 2018-- AXIM ® Biotechnologies, Inc., the world leader in cannabinoid research and development, announced today that it has entered into a binding distribution agreement for its proprietary ...
- GlobeNewswire•3 months ago
AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients
NEW YORK, Jan. 23, 2018-- AXIM ® Biotechnologies, Inc., the world leader in cannabinoid research and development, announced today that it has successfully completed an exploratory meeting with the Dutch ...
- InvestorPlace•3 months ago
How to Make Some Green From Marijuana Stocks
As marijuana legalization begins to slowly roll out state by state, it follows that marijuana-based businesses have cropped up, and many are trying their hand in the public markets. Regrettably, CANN is losing more and more money on marijuana services every year and is also burning cash.
- Zacks Small Cap Research•3 months ago
An Opportunity in the Medical Cannabinoid Industry: AXIM Biotechnologies (AXIM)
• During the fourth quarter of 2017, cannabis stocks climbed sharply (North American Marijuana Index +137%) reflecting increased investor interest and positive fundamental tailwinds. • AXIM Biotechnologies is well positioned to benefit from the overall medical cannabinoid investment theme and is expected to achieve significant milestones during 2018. Making its debut on the Toronto Stock Exchange in April 2017, the Horizons Medical Marijuana Life Sciences ETF (HMMJ.TO) sought to mimic the North American Medical Marijuana Index, a basket of publicly-listed North American companies with significant business activities in the marijuana industry.
- CNW Group•4 months ago
Alternate Health Begins Beta Testing of FlorPass Patient Management Software System in Key Market
Alternate Health Begins Beta Testing of FlorPass Patient Management Software System in Key Market
- PR Newswire•4 months ago
Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com
SAN ANTONIO , Dec. 11, 2017 /PRNewswire/ -- Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated medical cannabis ...
- CNW Group•4 months ago
Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com
Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com
- Marketwired•5 months ago
Leading CBD Provider Reports 255% Revenue Growth -- CFN Media
CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing why Medical Marijuana Inc. represents a compelling ...
- Capital Cube•5 months ago
AXIM Biotechnologies, Inc. breached its 50 day moving average in a Bullish Manner : AXIM-US : November 22, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AXIM Biotechnologies, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)
